Over 350 Total Lots Up For Auction at Three Locations - MD 02/08, TX 02/10, Ontario 02/14

Aidoc secures new FDA clearances for faster and more accurate detection of critical neurological and cardiovascular conditions

Press releases may be edited for formatting or style | November 18, 2022 Artificial Intelligence Cardiology
NEW YORK, Nov. 17, 2022 /PRNewswire/ -- Aidoc, the leading provider of healthcare AI solutions, today announced it has increased its FDA clearances to 11 with the addition of CT-based AI solutions - aortic dissection (AD) and all vessel occlusions (VOs). These clearances continue Aidoc's impressive momentum and leadership in healthcare AI, giving the organization the most FDA clearances in the AI imaging space.

With increased pressure on health systems due to the provider labor shortage, rising costs and COVID-19's ongoing impact, the need to provide more cost-effective quality care through earlier, faster treatment and more accurate interventions is imperative. Aidoc's clinical AI improves clinician efficiency, decreases the length of stay, and reduces turnaround time to mitigate average hospital costs, rising 15-25% since 20201.

These Aidoc solutions enable care teams across multiple service lines to not only identify patients in need of escalated care but further enhance cross-specialty provider workflows leading to decreased time to treatment and improved transfers, which may result in additional care-improving procedures.

Your Centrifuge Specialty Store

Quality remanufactured Certified Centrifuges at Great prices! Fully warranted and backed by a company you can trust! Call or click for a free quote today! www.Centrifugestore.com 800-457-7576

"Effective healthcare and treatment of acute conditions, like stroke and aortic dissections, require rapid, coordinated care– minutes can matter," said Aidoc CEO Elad Walach. "Our continued momentum with FDA-cleared solutions are not only aiding radiologists to prioritize potential findings, but we are helping connect other care team members immediately to the data needed to drive next actions and an optimized care plan. This leads to improved patient outcomes, such as reduced length of stay, and eases the communication burden on the care team because the right people are notified and engaged together."

Aidoc Gains First-Time FDA-Clearance to Flag All Large and Medium Vessel Occlusions

While existing products in the market detect only middle cerebral artery (MCA) M1 or internal carotid artery (ICA) occlusions, the latest vessel occlusion (VO) solution makes Aidoc the first and only company to gain clearance for triage and notification of all intracranial large VOs (LVOs) and more distal medium VOs (MeVOs) in the MCA, ICA, anterior cerebral artery (ACA), posterior cerebral artery (PCA), vertebral artery (VA) and basilar artery (BA). Now stroke teams have an option for an AI-driven workflow within a mobile app that provides reliable notification and convenient access to critical patient information and imaging for all LVO and MeVO patients - conditions where every minute matters.

You Must Be Logged In To Post A Comment